Jon S Odorico, MD
- Section of Kidney and Pancreas Surgery
- Division of Transplantation
Clinical Science Center
600 Highland Avenue
Madison WI 53792
- MD, New York University, School of Medicine, New York, NY
- Residency, General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
- Postdoctoral Research Fellow, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, PA
- Fellow, Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI
Dr. Odorico is certified by the American Board of Surgery. He specializes in pancreatic, islet cell, and multi-organ transplants.
Dr. Odorico’s research focuses on stem cell biology and differentiation, developing novel stem cell-based strategies for treating diabetes, pancreas transplantation, and islet cell transplantation.
Dr. Odorico’s lab
Conversion from Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of functional, safety and quality of life outcomes (CIRTEN SPK)
Study sponsor: University of Wisconsin-Madison
Study funding provided by: Veloxis Pharmaceuticals
Jon S. Odorico, MD, Principal Investigator
Non Invasive Blood Test to Diagnose Acute Rejection After Pancreas and Kidney Transplantation: Pancreas and Renal Rejection Diagnosis Using Circulating Donor-Derived Cell-free DNA in Peripheral Blood (PANCDx)
Study funding provided by: CareDx
Jon S. Odorico, MD, Sub-Investigator
Subcontract Agreement Amendment under negotiation, we expect to start enrollment in the first quarter of 2020
Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen.
Wang C, Lai AY, Baiu DC, Smith KA, Odorico JS, Wilson K, Schreiber T, de Silva S, Gumperz JE
J Immunol 2023 Nov 22;
[PubMed ID: 37991420]
Risk factors and outcomes of persistent post-transplant hypotension among simultaneous pancreas and kidney transplant recipients.
Aziz F, Mandelbrot D, Jorgenson M, Muth B, Baltaji A, Pantha M, Kaufman D, Odorico J, Parajuli S
Clin Transplant 2023 Nov 17; e15197
[PubMed ID: 37975526]
Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant Recipients.
Descourouez JL, Smith JA, Saddler CM, Mandelbrot DA, Odorico JS, Jorgenson MR
Ann Pharmacother 2023 Oct 28; 10600280231207899
[PubMed ID: 37897238]
LCP-Tacrolimus Requires a Similar Empiric Dose Adjustment to Immediate-Release Tacrolimus When Given Concomitantly With Letermovir for Cytomegalovirus Primary Prophylaxis.
Descourouez JL, Mandelbrot DA, Odorico J, Jorgenson MR
Ann Pharmacother 2023 Oct 27; 10600280231208430
[PubMed ID: 37887433]
Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell-mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods.
Drachenberg CB, Buettner-Herold M, Aguiar PV, Horsfield C, Mikhailov AV, Papadimitriou JC, Seshan SV, Perosa M, Boggi U, Uva P, Rickels M, Grzyb K, Arend L, Cuatrecasas M, Toniolo MF, Farris AB, Renaudin K, Zhang L, Roufousse C, Gruessner A, Gruessner R, Kandaswamy R, White S, Burke G, Cantarovich D, Parsons RF, Cooper M, Kudva YC, Kukla A, Haririan A, Parajuli S, Merino-Torres JF, Argente-Pla M, Meier R, Dunn T, Ugarte R, Rao JS, Vistoli F, Stratta R, Odorico J
Am J Transplant 2023 Oct 21;
[PubMed ID: 37871799]